Impact of a 24/7 multiplex-PCR on the management of patients with confirmed viral meningitis.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
12 2021
Historique:
received: 24 05 2021
revised: 13 08 2021
accepted: 31 08 2021
pubmed: 10 10 2021
medline: 25 12 2021
entrez: 9 10 2021
Statut: ppublish

Résumé

The relevance of syndromic multiplex-PCR for the etiological diagnosis of meningitis or meningoencephalitis is still a matter of debate. Here, we studied the impact of a 24/7 multiplex-PCR on the management of patients consulting in the emergency department for suspicion of community-acquired meningitis. We conducted a single-center retrospective study at the Emergency department of Lariboisière University Hospital (Paris, France) including all patients suspected of meningitis. During period 1 (April 2014-March 2017), the molecular assays used for the detection of infectious agents in the cerebrospinal fluid (CSF) were performed during the daytime. During period 2 (April 2017-March 2019), multiplex-PCR (BioFire® Filmarray® Meningitis/Encephalitis Panel [ME], bioMérieux) was performed 24/7. During the periods 1 and 2, 4 100 and 3 574 patients were included and 284 (6.9%) and 308 (8.6%) meningitis were diagnosed, respectively. During the periods 1 and 2, the most common causes of meningitis were enterovirus (23.9% and 29.5%), varicella zoster virus (10.2% and 6.8%) and herpes simplex virus-2 (4.2% and 8.1%). For patients with confirmed viral meningitis, a significant decrease was found between period 1 and period 2, respectively for the rate of hospitalization (73.9% vs 42.0%; p < 0.05), the length of stay (3[2–5] vs 2[1–3] days; p < 0.05), the empirical antiviral (26.1% vs 14.5%) and antibacterial administrations (29.3% vs 14.5%; p < 0.05). Multiplex-PCR is an important tool in the diagnosis of infectious meningitis in the emergency department and is relevant in the management of meningitis by screening for patients who do not require hospitalization and antibacterial therapy.

Identifiants

pubmed: 34626699
pii: S0163-4453(21)00496-5
doi: 10.1016/j.jinf.2021.08.050
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-655

Déclaration de conflit d'intérêts

Declaration of Competing Interest None to declare.

Auteurs

Gauthier Péan de Ponfilly (G)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Laboratoire de Microbiologie Clinique et Plateforme de dosage des anti-infectieux, Groupe Hospitalier Paris Saint Joseph, Paris, France. Electronic address: gpeandeponfilly@ghpsj.fr.

Anthony Chauvin (A)

Emergency Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Maud Salmona (M)

Unit of Virology and Graft, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, Paris, France; Université de Paris, Inserm U976, team INSIGHT, Paris F-75010, France.

Hanaa Benmansour (H)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Béatrice Bercot (B)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université de Paris, IAME UMR 1137 INSERM, Paris F-75018, France.

Francois Camelena (F)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université de Paris, IAME UMR 1137 INSERM, Paris F-75018, France.

Virginie Courbin (V)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Xavier Eyer (X)

Emergency Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Emmanuel Lecorche (E)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université de Paris, IAME UMR 1137 INSERM, Paris F-75018, France.

Faïza Mougari (F)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Anne-Lise Munier (AL)

Department of Infectious Diseases, Service de Microbiologie, APHP, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, 2 rue Ambroise Paré, Paris 75010, France.

Eric Revue (E)

Emergency Department, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

Jérôme LeGoff (J)

Unit of Virology and Graft, Infectious Agents Department, Saint Louis-Lariboisiere-Fernand Widal University Hospital, APHP, Paris, France; Université de Paris, Inserm U976, team INSIGHT, Paris F-75010, France.

Emmanuelle Cambau (E)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université de Paris, IAME UMR 1137 INSERM, Paris F-75018, France.

Hervé Jacquier (H)

Laboratory of Microbiology, Saint Louis-Lariboisiere-Fernand Widal Hospital Group, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université de Paris, IAME UMR 1137 INSERM, Paris F-75018, France. Electronic address: herve.jacquier@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH